Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women: a prospective combined analysis of two multicenter trials.
Robertson JF, Osborne CK, Howell A, Jones SE, Mauriac L, Ellis M, Kleeberg UR, Come SE, Vergote I, Gertler S, Buzdar A, Webster A, Morris C. Robertson JF, et al. Among authors: howell a. Cancer. 2003 Jul 15;98(2):229-38. doi: 10.1002/cncr.11468. Cancer. 2003. PMID: 12872340 Free article. Clinical Trial.
ATAC trial did not report interim results.
Baum M, Buzdar A, Howell A. Baum M, et al. Among authors: howell a. BMJ. 2003 Nov 1;327(7422):1050. doi: 10.1136/bmj.327.7422.1050. BMJ. 2003. PMID: 14593064 Free PMC article. No abstract available.
Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial.
Howell A, Robertson JF, Abram P, Lichinitser MR, Elledge R, Bajetta E, Watanabe T, Morris C, Webster A, Dimery I, Osborne CK. Howell A, et al. J Clin Oncol. 2004 May 1;22(9):1605-13. doi: 10.1200/JCO.2004.02.112. J Clin Oncol. 2004. PMID: 15117982 Clinical Trial.
Are aromatase inhibitors superior to antiestrogens?
Howell A, Buzdar A. Howell A, et al. J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):237-47. doi: 10.1016/j.jsbmb.2005.02.004. J Steroid Biochem Mol Biol. 2005. PMID: 15860266 Review.
Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer.
Cella D, Fallowfield L, Barker P, Cuzick J, Locker G, Howell A; ATAC Trialistsa9 Group. Cella D, et al. Among authors: howell a. Breast Cancer Res Treat. 2006 Dec;100(3):273-84. doi: 10.1007/s10549-006-9260-6. Epub 2006 Jun 21. Breast Cancer Res Treat. 2006. PMID: 16944295 Clinical Trial.
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.
Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group; Forbes JF, Cuzick J, Buzdar A, Howell A, Tobias JS, Baum M. Arimidex, Tamoxifen, Alone or in Combination (ATAC) Trialists' Group, et al. Among authors: howell a. Lancet Oncol. 2008 Jan;9(1):45-53. doi: 10.1016/S1470-2045(07)70385-6. Lancet Oncol. 2008. PMID: 18083636 Clinical Trial.
1,285 results